NRx Pharmaceuticals, Inc. ( NRXP) - Key Metrics
NRXP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.03 | $0.01 | -$0.12 | -$0.12 |
| 2025Q3 | $0.01 | -$0.26 | -$0.13 | -$0.13 |
| 2025Q2 | ? | -$0.98 | -$0.22 | -$0.22 |
| 2025Q1 | ? | -$0.34 | -$0.21 | -$0.21 |
NRXP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 59.72 |
| 2025Q3 | ? | -3.11 |
| 2025Q2 | ? | -0.83 |
| 2025Q1 | ? | -1.53 |
NRXP Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -6.24% | ? |
| 2025Q4 | -4.32% | ? |
| 2025Q3 | -3.94% | ? |
| 2025Q2 | -6.89% | ? |
| 2025Q1 | -10.34% | ? |
NRXP
Price: $3.97
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 246900
Market Capitalization: 71.6 million